Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease V. Tabar, H. Sarva, A. M. Lozano, A. Fasano, S. K. Kalia, K. K. H. Yu, C. Brennan, Y. Ma, S. Peng, D. Eidelberg, M. Tomishima, S. Irion, W. Stemple, N. Abid, A. Lampron, L. Studer & C. Henchcliffe For millions of people living withContinueContinue reading “Replacing Lost Neurons in Parkinson’s Disease: Early Clinical Results of Bemdaneprocel”